(Q37378440)

20 August 2017

Rationale for the evaluation of fluoxetine in the treatment of enterovirus D68-associated acute flaccid myelitis (English)

1 reference

20 August 2017

1 reference

Kenneth L Tyler

1

1 reference

PMC publication ID

5086417

20 August 2017

language of work or name

English

0 references

publication date

1 May 2015

1 reference

20 August 2017

1 reference

20 August 2017

72

1 reference

20 August 2017

5

1 reference

20 August 2017

493-494

1 reference

Selective serotonin reuptake inhibitor fluoxetine inhibits replication of human enteroviruses B and D by targeting viral protein 2C.

20 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

Fluoxetine is a potent inhibitor of coxsackievirus replication

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

Acute flaccid paralysis with anterior myelitis - California, June 2012-June 2014.

6 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

MRI findings in children with acute flaccid paralysis and cranial nerve dysfunction occurring during the 2014 enterovirus D68 outbreak

26 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

Acute neurologic illness of unknown etiology in children - Colorado, August-September 2014.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

The thiazolobenzimidazole TBZE-029 inhibits enterovirus replication by targeting a short region immediately downstream from motif C in the nonstructural protein 2C.

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

Fluoxetine pharmacokinetics in pediatric patients

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

Fluorine magnetic resonance spectroscopy measurement of brain fluvoxamine and fluoxetine in pediatric patients treated for pervasive developmental disorders

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

Human brain fluoxetine concentrations

2 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5086417

10.1001/JAMANEUROL.2014.4625

2 September 2018

Identifiers

DOI

1 reference

20 August 2017

1 reference

PMC publication ID

5086417

20 August 2017

PubMed publication ID

25775436

1 reference

PMC publication ID

5086417